Per-oral cholangioscopy in patients with primary sclerosing cholangitis: a 12-month follow-up study

Abstract

Background and study aims Patients with primary sclerosing cholangitis (PSC) have a 9% to 20% lifetime incidence of cholangiocarcinoma (CCA). Per-oral cholangioscopy (POCS) added to endoscopic retrograde cholangiography (ERC) could potentially improve detection of CCA occurrence. We prospectively assessed POCS identification of 12-month CCA incidence in PSC patients undergoing ERC.

Patients and methods Consecutive patients with PSC, an indication for ERC, and no prior liver transplantation were enrolled. During the index procedure, POCS preceded planned therapeutic maneuvers. The primary endpoint was ability for POCS visualization with POCS-guided biopsy to identify CCA during 12-month follow-up. Secondary endpoints included ability of ERC/cytology to identify CCA, repeat ERC, liver transplantation, and serious adverse events (SAEs).

Results Of 42 patients enrolled, 36 with successful cholangioscope advancement were analyzed. Patients had a mean age 43.5±15.6 years and 61% were male. Three patients diagnosed with CCA had POCS visualization impressions of benign/suspicious/suspicious, and respective POCS-guided biopsy findings of suspicious/positive/suspicious for malignancy at the index procedure. The three CCA cases had ERC visualization impressions of benign/benign/suspicious, and respective cytology findings of atypical/atypical/suspicious for malignancy. No additional patients were diagnosed with CCA during median 11.5-month follow-up. Twenty-three repeat ERCs (5 including POCS) were performed in 14 patients. Five patients had liver transplantation, one after CCA diagnosis and four after benign cytology at the index procedure. Three patients (7.1%) had post-ERC pancreatitis. No SAEs were POCS-related.

Conclusions In PSC patients, POCS visualization/biopsy and ERC/cytology each identified three cases of CCA. Some patients had a repeat procedure and none experienced POCS-related SAEs.

Keywords

Cholangioscopy - Pancreatobiliary (ERCP/PTCD) - Diagnostic ERC - Endoscopy Upper GI Tract - Malignant strictures

Publikationsverlauf

Eingereicht: 06. September 2023

Angenommen nach Revision: 22. Dezember 2023

Accepted Manuscript online:
02. Januar 2024

Artikel online veröffentlicht:
15. Februar 2024

• References

• 1 Dyson JK, Beuers U, Jones DEJ. et al. Primary sclerosing cholangitis. Lancet 2018; 391: 2547-2559
• 2 Song J, Li Y, Bowlus CL. et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC): a comprehensive review. Clin Rev Allergy Immunol 2020; 58: 134-149
• 3 Barkin JA, Levy C, Souto EO. Endoscopic management of primary sclerosing cholangitis. Ann Hepatol 2017; 16: 842-850
• 4 Bowlus CL, Lim JK, Lindor KD. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review. Clin Gastroenterol Hepatol 2019; 17: 2416-2422
• 5 Bowlus CL, Arrive L, Bergquist A. et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77: 659-702
• 6 Ponsioen CY, Assis DN, Boberg KM. et al. Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process. Gastroenterology 2021; 161: 1764-1775
• 7 Aabakken L, Karlsen TH, Albert J. et al. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy 2017; 49: 588-608
• 8 Tejaswi S, Olson KA, Loehfelm TW. Cholangioscopy in primary sclerosing cholangitis: a case series of dominant strictures and cholangiocarcinoma. VideoGIE 2021; 6: 277-281
• 9 Bangarulingam SY, Bjornsson E, Enders F. et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology 2010; 51: 174-180
• 10 Navaneethan U, Njei B, Venkatesh PG. et al. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 2014; 79: 943-950
• 11 Kaura K, Sawas T, Bazerbachi F. et al. Cholangioscopy biopsies improve detection of cholangiocarcinoma when combined with cytology and FISH, but not in patients with PSC. Dig Dis Sci 2020; 65: 1471-1478
• 12 Fung BM, Fejleh MP, Tejaswi S. et al. Cholangioscopy and its Role in Primary Sclerosing Cholangitis. Eur Med J Hepatol 2020; 8: 42-53
• 13 Liu R, Cox Rn K, Siddiqui A. et al. Peroral cholangioscopy facilitates targeted tissue acquisition in patients with suspected cholangiocarcinoma. Minerva Gastroenterol Dietol 2014; 60: 127-133
• 14 Azeem N, Gostout CJ, Knipschield M. et al. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. Gastrointest Endosc 2014; 79: 773-779
• 15 Charatcharoenwitthaya P, Enders FB, Halling KC. et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008; 48: 1106-1117
• 16 Forbes N, Mohamed R, Heitman S. et al. Tu1534 Detection of cholangiocarcinoma in patients with primary sclerosing cholangitis using single-operator cholangioscopy: a prospective evaluation and cost analysis. Gastrointestinal Endoscopy 2016; 83: AB598-AB599
• 17 Nanda A, Brown JM, Berger SH. et al. Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma. Therap Adv Gastroenterol 2015; 8: 56-65
• 18 Levy MJ, Baron TH, Clayton AC. et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol 2008; 103: 1263-1273
• 19 Ponsioen CY, Vrouenraets SM, Prawirodirdjo W. et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002; 51: 562-566
• 20 Boyd S, Mustonen H, Tenca A. et al. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma. Scand J Gastroenterol 2017; 52: 242-249
• 21 Tischendorf JJ, Kruger M, Trautwein C. et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 2006; 38: 665-669
• 22 Ponsioen CY, Vrouenraets SM, van Milligen de Wit AW. et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999; 31: 305-309
• 23 Siqueira E, Schoen RE, Silverman W. et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002; 56: 40-47
• 24 Lindberg B, Arnelo U, Bergquist A. et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 2002; 34: 909-916
• 25 Lal A, Okonkwo A, Schindler S. et al. Role of biliary brush cytology in primary sclerosing cholangitis. Acta Cytol 2004; 48: 9-12
• 26 Furmanczyk PS, Grieco VS, Agoff SN. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19–9 levels. Am J Clin Pathol 2005; 124: 355-360
• 27 Boberg KM, Jebsen P, Clausen OP. et al. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 2006; 45: 568-574
• 28 Moff SL, Clark DP, Maitra A. et al. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. J Clin Gastroenterol 2006; 40: 336-341
• 29 Moreno Luna LE, Kipp B, Halling KC. et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 2006; 131: 1064-1072
• 30 Halme L, Arola J, Numminen K. et al. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity. Liver Int 2012; 32: 783-789
• 31 Heif M, Yen RD, Shah RJ. ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients. Dig Dis Sci 2013; 58: 2068-2074
• 32 Dhaliwal AS, Naga Y, Ramai D. et al. A comparison of balloon- versus stent-based approach for dominant strictures in primary sclerosing cholangitis: a meta-analysis. Ann Gastroenterol 2022; 35: 307-316
• 33 Chapman RW, Williamson KD. Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma?. Curr Hepatol Rep 2017; 16: 124-129
• 34 Fujisawa T, Ushio M, Takahashi S. et al. Role of peroral cholangioscopy in the diagnosis of primary sclerosing cholangitis. Diagnostics (Basel) 2020; 10: 268